SC

Sanjay Chaturvedi

Active Director Director DIN 09616204
DIN 09616204 First appointment May 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Sanjay Chaturvedi

Data last updated:

Sanjay Chaturvedi is a Director at Maxelder Pharma Private Limited (since 2022). The company operates in Pharma. Maxelder Pharma Private Limited reported revenue of ₹6.41 Cr (FY 2025).

DIN 09616204
Primary Designation Director
Industry Pharma
First Appointment 25 May 2022
Oldest Company Age 6 yrs
Largest company Maxelder Pharma Private Limited · ₹6.41 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maxelder Pharma Private Limited U51909UP2020PTC134028
Director25 May 20222020₹6.41 Cr (FY 2025)Active

Board colleagues of Sanjay Chaturvedi

NameDINCompanyDesignation
Beenu Jain05265264Maxelder Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Maxelder Pharma Private Limited
Premium access

Shareholding and investment profile for Sanjay Chaturvedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Chaturvedi

Sanjay Chaturvedi currently holds 1 directorship: Maxelder Pharma Private Limited (Director, since 25 May 2022, revenue ₹6.41 Cr (FY 2025)).

Sanjay Chaturvedi was first appointed on 25 May 2022 as Director at Maxelder Pharma Private Limited.

The current boards of Sanjay Chaturvedi's companies include Beenu Jain (Maxelder Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available